Abivax stock price target raised to $114 from $95 at JMP Securities
PositiveFinancial Markets

Abivax has received a significant boost as JMP Securities has raised its stock price target from $95 to $114. This adjustment reflects growing confidence in the company's potential and could attract more investors, signaling a positive outlook for Abivax's future performance in the market.
— Curated by the World Pulse Now AI Editorial System